MRMD - MariMed Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
-0.20 (-4.41%)
At close: 3:59PM EST
Stock chart is not supported by your current browser
Previous Close4.54
Bid0.00 x 0
Ask0.00 x 0
Day's Range3.92 - 4.45
52 Week Range0.46 - 5.80
Avg. Volume747,929
Market Cap904.452M
Beta (3Y Monthly)3.50
PE Ratio (TTM)N/A
EPS (TTM)-0.11
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • GlobeNewswire8 hours ago

    MariMed Reports Third Quarter 2018 Financial Results

    NORWOOD, MA, Nov. 20, 2018 (GLOBE NEWSWIRE) --  MariMed Inc. (MRMD), a multi-state cannabis operator, reported third quarter 2018 financial results for the quarter and nine months ended September 30, 2018. The Company continued to grow quarterly year-over-year revenue since the second quarter of 2016. Operating income increased 75% to approximately $2.0 from approximately $1.1 million during the nine months ended September 30, 2017.

  • Benzinga6 days ago

    The 10 Most Actively Traded OTCQX And OTCQB Stocks In October

    When the market is volatile, investors flee to safety. Often, investors will retreat out of growth names and into more established industries. We saw that trend play out in October on the over-the-counter ...

  • Better Marijuana Stock: MariMed Inc. vs. The Green Organic Dutchman Holdings Ltd.
    Motley Fool6 days ago

    Better Marijuana Stock: MariMed Inc. vs. The Green Organic Dutchman Holdings Ltd.

    If you could only buy one of these marijuana stocks, here's the better choice.

  • The Big Election Win for Marijuana Hardly Anyone Is Talking About
    Motley Fool7 days ago

    The Big Election Win for Marijuana Hardly Anyone Is Talking About

    This state didn't vote to legalize recreational marijuana, but it did the next best thing.

  • Benzinga8 days ago

    MariMed, GenCanna Global Form Hemp Partnership

    A new company is set to join the growing hemp market. MariMed Inc  (OTC: MRMD ) has agreed to invest $30 million in GenCanna Global as part of a strategic partnership.  What Happened MariMed develops and ...

  • GlobeNewswire8 days ago

    MariMed Enters Fast-Growing Hemp CBD World Market in Partnership with GenCanna Global

    WINCHESTER, KY and NEWTON, MA, Nov. 12, 2018 (GLOBE NEWSWIRE) --  MariMed Inc. (MRMD) and GenCanna Global Inc. (“GenCanna”) jointly announced today that the companies have entered into an agreement whereby MariMed has invested $30 million in GenCanna, and the companies have created a strategic partnership, including a long-term supply agreement. The partnership expands MariMed’s robust product development capabilities and strengthens GenCanna’s position as a global leader in the Hemp CBD industry.

  • The 7 Best Stocks to Buy Now That Jeff Sessions Is Gone
    InvestorPlace12 days ago

    The 7 Best Stocks to Buy Now That Jeff Sessions Is Gone

    When the dust settled from the midterm elections, President Donald Trump did something both shocking and inevitable: he fired Attorney General Jeff Sessions. Occupying a contentious tenure from the start, Sessions passive-aggressively clashed with Trump by recusing himself from the Russian-meddling inquiry. Political insiders characterized Sessions as having a “tough sheriff” personality.

  • ACCESSWIRE13 days ago

    Marijuana Stocks Moving Higher On Breaking News

    CORAL GABLES, FL / ACCESSWIRE / November 7,2018 / Medical cannabis and recreational marijuana have been put in a very bright spotlight on Wednesday. Missouri and Utah approved medical marijuana initiatives, joining 31 other states that already allow prescription sales. ICC International Cannabis Corp. (KNHBF) (WRLD) a has held its trading level around $0.50 for the last week and on the heels of major marijuana market developments, the company announced today that it has received an inaugural purchase order for 10,000mL of Tetrahydrocannabinol Cannabis oil, 5,000g of dried Cannabis flower and 5,000mL of Cannabidiol oil.

  • GlobeNewswire13 days ago

    MariMed Hires Cannabis Analyst Charles Finnie as Chief Strategy Officer

    Finnie to lead MariMed M&A, strategic investment, corporate strategy, investor relations Finnie sees biggest opportunity in undervalued US cannabis companies NORWOOD,.

  • ACCESSWIRE14 days ago

    CBD Stocks on The Rebound

    HENDERSON, NV / ACCESSWIRE / November 6, 2018 / As the stock market plummeted early October cannabis companies stayed strong, buoyed up by legislative changes in Canada. The cannabis market appears set ...

  • The 5 Top-Performing Marijuana Stocks Since the Beginning of 2016
    Motley Fool14 days ago

    The 5 Top-Performing Marijuana Stocks Since the Beginning of 2016

    The best pot stock is up more than 6,700% in less than three years.

  • Investopedia14 days ago

    Marijuana and Midterms: What You Need to Know

    The legalization of medical marijuana and recreational marijuana have emerged as key talking points in the run up to the election. Seven states have already legalized recreational marijuana, while roughly 30 other states have passed medical cannabis in some form. On Tuesday, four more states could be added to those lists. Legalization of the drug for recreational use is on the ballot in North Dakota and Michigan, while voters in Missouri and Utah will decide whether to legalize cannabis for medical purposes.

  • Why This Marijuana Stock Jumped 19% in October While the Group Got Clobbered
    Motley Fool15 days ago

    Why This Marijuana Stock Jumped 19% in October While the Group Got Clobbered

    U.S.-based MariMed bucked the downtrend in the cannabis sector last month. Here's what investors should know.

  • GlobeNewswire15 days ago

    MariMed Co-Sponsoring  Maryland Medical Cannabis Forum Nov. 8 in Baltimore

    In-depth discussion of Medical Marijuana Research and PracticeFeatured speakers Dr. Jokūbas Žiburkus (Canntelligence), Dr. Dustin Sulak (,Panel hosted by CNBC’s.

  • The 3 Best Marijuana Stocks in October
    Motley Fool19 days ago

    The 3 Best Marijuana Stocks in October

    Or, should I say, the only three pot stocks to finish in the green last month.

  • 7 U.S. Marijuana Stocks to Buy for the Midterm Elections
    InvestorPlace20 days ago

    7 U.S. Marijuana Stocks to Buy for the Midterm Elections

    Naturally, this has significant implications for marijuana stocks. Favorable legislation stateside and in Canada boosted marijuana stocks like Tilray (NASDAQ:TLRY) into the stratosphere. While the pain is extremely pronounced for pot stocks, I believe the political environment presents high-risk/high-reward contrarian opportunities.

  • Why MariMed Inc. Stock Is on the Rise Today
    Motley Fool22 days ago

    Why MariMed Inc. Stock Is on the Rise Today

    The company acquires a consultancy for the cannabis industry ahead of New Jersey's vote to potentially legalize recreational pot.

  • GlobeNewswire22 days ago

    MariMed Acquires NJ-Based BSC Group Cannabis Firm; Strengthens Operations, Branding Teams

    MariMed Inc., a multi-state cannabis organization that develops, owns and manages cannabis facilities and branded products lines, announced today that it has finalized the acquisition of BSC Group, a highly respected cannabis firm headquartered in New Jersey that over the last three years has been engaged in competitive licensing, consulting and operations management across the country. BSC founders and managing partners, Brian Staffa and Amber Staffa, will join the MariMed leadership team, bringing under the MariMed umbrella their extensive cannabis expertise, resources, intellectual property and a vast network of highly specialized affiliates spanning regulated fields of commercial cannabis, food and beverage, commercial agriculture, pharmaceuticals, regulatory compliance, consumer psychology, and the applied sciences.

  • Better Marijuana Stock: Aurora Cannabis vs. MariMed
    Motley Fool23 days ago

    Better Marijuana Stock: Aurora Cannabis vs. MariMed

    Which stock wins in a one-on-one battle between a big Canadian cannabis producer and a top U.S. cannabis company?

  • ACCESSWIRE27 days ago

    Stock Nearly Doubles on Huge News

    HENDERSON, NV / ACCESSWIRE / October 24, 2018 / While many equities took losses on Tuesday one stock we found nearly doubled its price on the heels of some huge news. OriginClear, Inc. (OCLN) started what ...

  • Investopedialast month

    What Stocks are on the Marijuana Index?

    U.S. Marijuana Index, compiled by Marijuana International Corporation, has delivered 158% returns over the past one year, as of October 17, 2018. Though the market saw a lot of volatility in marijuana policy during the course of the year on account of hard line policy stance taken by the new U.

  • GlobeNewswirelast month

    MariMed to be Featured at Canaccord Genuity U.S. Cannabis Symposium

    Fireman, CEO of 2018 Top Performing Cannabis Stock, will share insight on MariMed, U.S. cannabis market opportunity NEWTON, MA and TORONTO, Oct. 17, 2018 --  MariMed Inc..

  • ACCESSWIRElast month

    CBD Beverages Drawing Major Attention

    HENDERSON NV / ACCESSWIRE / October 11, 2018 / Some of the world's biggest beverage makers are looking to add cannabis-infused drinks to their lineups. Corona brewer Constellation Brands said last month ...

  • ACCESSWIRElast month

    MariMed Continues to Grow with the Expansion of Legal Cannabis Initiatives

    NEW YORK, NY / ACCESSWIRE / October 11, 2018 / Traders News Source, a leading independent equity research and corporate access firm focused on small and mid-cap public companies is issuing a comprehensive ...

  • ACCESSWIRE2 months ago

    3 Pot Stocks Taking Advantage of the Cannabis Boom

    CORAL GABLES, FL / ACCESSWIRE / October 5, 2018 / The cannabis market is attracting many new investors recently and the upcoming Canadian legalization has spawned added growth for marijuana stocks. The Drug Enforcement Administration recently placed Epidiolex, a drug that includes cannabis-derived compounds - specifically, cannabidiol (CBD) - in Schedule V. The DEA move takes a broad look at how the FDA is conducting its business, placing "certain drug products that have been approved by the [FDA] and which contain [CBD] in schedule V of the Controlled Substances Act (CSA)," according to the DEA order.